These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 2339367)
21. Selective activation of heparin cofactor II by a sulfated polysaccharide isolated from the leaves of Artemisia princeps. Hayakawa Y; Hayashi T; Hayashi T; Niiya K; Sakuragawa N Blood Coagul Fibrinolysis; 1995 Oct; 6(7):643-9. PubMed ID: 8562835 [TBL] [Abstract][Full Text] [Related]
22. Purification and properties of guinea pig antithrombin III. Heck L; Rosenberg R; Remold H Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072 [TBL] [Abstract][Full Text] [Related]
23. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III. Nagasawa K; Uchiyama H J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227 [TBL] [Abstract][Full Text] [Related]
24. Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analogues. Jeske W; Fareed J Semin Thromb Hemost; 1993; 19 Suppl 1():241-7. PubMed ID: 8362268 [TBL] [Abstract][Full Text] [Related]
25. Practical considerations on the measurement of low molecular weight heparin anti-Xa activity. Aiach M; Roncato M Semin Thromb Hemost; 1985 Apr; 11(2):108-11. PubMed ID: 4035362 [No Abstract] [Full Text] [Related]
26. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method. Frantzen Handeland G; Abildgaard U; Aasen AO Scand J Haematol; 1983 Nov; 31(5):427-36. PubMed ID: 6648356 [TBL] [Abstract][Full Text] [Related]
27. An improved clinical assay for antithrombin III (heparin cofactor). Chockley M; Penner JA Am J Clin Pathol; 1980 Aug; 74(2):213-7. PubMed ID: 7405901 [TBL] [Abstract][Full Text] [Related]
28. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies. Ototani N; Kikuchi M; Yosizawa Z Biochem J; 1982 Jul; 205(1):23-30. PubMed ID: 7126178 [TBL] [Abstract][Full Text] [Related]
29. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma. Ofosu FA; Modi G; Cerskus AL; Hirsh J; Blajchman MA Thromb Res; 1982 Nov; 28(4):487-97. PubMed ID: 7164033 [TBL] [Abstract][Full Text] [Related]
30. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides. Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917 [TBL] [Abstract][Full Text] [Related]
31. Increased concentrations of heparin cofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin III. Gram J; Jespersen J Clin Chem; 1989 Jan; 35(1):52-5. PubMed ID: 2910581 [TBL] [Abstract][Full Text] [Related]
33. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma. Simmons RB; Newton GR; Doctor VM Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997 [TBL] [Abstract][Full Text] [Related]
34. A sensitive colorimetric assay for thrombin, prothrombin and antithrombin III in human plasma using a new synthetic substrate. Hitomi Y; Kanda T; Niinobe M; Fujii S Clin Chim Acta; 1982 Mar; 119(3):157-64. PubMed ID: 6461438 [TBL] [Abstract][Full Text] [Related]
35. The influence of molecular weight on the biological activity of heparin like sulphated hyaluronic acids. Barbucci R; Lamponi S; Magnani A; Renier D Biomaterials; 1998; 19(7-9):801-6. PubMed ID: 9663756 [TBL] [Abstract][Full Text] [Related]
36. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia. Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208 [TBL] [Abstract][Full Text] [Related]
37. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma. Abildgaard U; Larsen ML Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786 [TBL] [Abstract][Full Text] [Related]
39. A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915). Asai K; Asai M Clin Chim Acta; 1984 Dec; 144(2-3):163-71. PubMed ID: 6397281 [TBL] [Abstract][Full Text] [Related]
40. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II]. Zhang G Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):126-9. PubMed ID: 15622771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]